CD8A and malignant colon neoplasm: These OVA-specific CD8+ T cells were cocultured with MC38-OVA-GFP colon cancer cells for 4 days, at an effect and target ratio of 1-to-2, and anti–PD-1 antibody was added as indicated (Figure 1A).